Research Grants 14 show all


$2.6M
2007

$1.8M
2008

$1.6M
2009

$1.8M
2010

$260.6K
2011

Patents 44show all

  • 21
    A61K - Preparations for medical, dental, or toilet purposes
  • 18
    C12N - Microorganisms or enzymes
  • 7
    C07D - Heterocyclic compounds
  • 4
    C07K - Peptides
  • 4
    Y02A - Technologies for adaptation to climate change
  • 3
    B03D - Flotation
  • 3
    C07H - Sugars
  • 3
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 2
    B01D - Separation
  • 2
    C07C - Acyclic or carbocyclic compounds

Clinical Trials 1show all

1Phase 1

SEC Filings show all


3
D

Contact Information

Pleasanton, CA
United States

SEC Form D Funding Events

DateOfferedSoldType
2010-10-26$2,000,000$750,000Debt, Option to Acquire
2009-09-24$25,150,000$15,136,247Equity
2008-12-08Unknown Unknown Other (Paper Filing)

Key Executives

  • Grant E. Pickering
    Executive Officer, Director
  • Kimberlee Gonzaga
    Executive Officer
  • Carol L. Brosgart
    Director
  • Michael Ross
    Director
  • Thomas P. Monath
    Director
  • Lewis T. Williams
    Director